VRP.L Regulatory News (VRP)

15 Oct 2012 14:01

Director Shareholding

15 October 2012 - London, UK - Verona Pharma plc (AIM: VRP.L) (the "Company") has received notification that on 12 October 2012, Jan-Anders Karlsson, CEO and a director of the Company, acquired an interest in 150,000 ordinary shares of 0.1p each in the Company ("Ordinary Shares") at a price of 4.5 pence per share.

Following the acquisition, Dr. Karlsson will have an interest in the Company of 150,000 Ordinary Shares, representing 0.05% of the Company's issued ordinary share capital.

-Ends-

For more information please contact:

Verona Pharma plc Tel: 020 7863 3300 Jan-Anders Karlsson, CEO info@veronapharma.com WH Ireland Group Plc Tel: 020 7220 1650 Chris Fielding Chris.fielding@WH-Ireland.Co.UK